1. Home
  2. TWIN vs TLSI Comparison

TWIN vs TLSI Comparison

Compare TWIN & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Twin Disc Incorporated

TWIN

Twin Disc Incorporated

HOLD

Current Price

$17.49

Market Cap

269.7M

Sector

Industrials

ML Signal

HOLD

Logo TriSalus Life Sciences Inc.

TLSI

TriSalus Life Sciences Inc.

HOLD

Current Price

$2.61

Market Cap

270.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TWIN
TLSI
Founded
1918
2010
Country
United States
United States
Employees
N/A
102
Industry
Industrial Machinery/Components
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
269.7M
270.2M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
TWIN
TLSI
Price
$17.49
$2.61
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
50.8K
476.6K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
0.98%
N/A
EPS Growth
N/A
N/A
EPS
1.76
N/A
Revenue
$340,738,000.00
N/A
Revenue This Year
$10.79
$35.45
Revenue Next Year
$8.43
$37.58
P/E Ratio
$10.28
N/A
Revenue Growth
15.45
N/A
52 Week Low
$6.90
$2.20
52 Week High
$19.67
$7.95

Technical Indicators

Market Signals
Indicator
TWIN
TLSI
Relative Strength Index (RSI) 50.60 23.53
Support Level $14.38 N/A
Resistance Level $18.95 $5.41
Average True Range (ATR) 1.27 0.30
MACD 0.05 -0.22
Stochastic Oscillator 56.66 18.77

Price Performance

Historical Comparison
TWIN
TLSI

About TWIN Twin Disc Incorporated

Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, for patients with solid tumors. The company developed Pressure-Enabled Drug Delivery (PEDD) to overcome high intratumoral pressure and off-target delivery. Its 510(k) cleared device, the TriNav Infusion System using PEDD technology, is used for interventional radiology procedures including transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or liver metastases. It has one reportable segment and generates revenue from sales of PEDD infusion systems, principally related to TriNav.

Share on Social Networks: